Rabegen

Rabegen Warnings

Manufacturer:

Inventia Healthcare

Distributor:

InnoGen Pharmaceuticals
Full Prescribing Info
Warnings
Symptomatic response to rabeprazole does not preclude the presence of gastric malignancy. Atrophic gastritis has been noted occasionally in gastric corpus biopsies from patients treated long-term with benzimidazoles to which group rabeprazole also belongs.
Rabeprazole, like other proton pump inhibitors, has potential to cause gastric carcinoids but the studies have not been conclusive. Rabeprazole Sodium + Itopride Hydrochloride capsules must not be opened, chewed or crushed; they should be swallowed as whole.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in